Workplace Analytics and AI-Powered Skills-Mapping Platforms Named ISG Startup Challenge Winners
Audiences at ISG Future Workplace Summits vote for tech startups that measure digital workforce productivity,…
Month: March 2023
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Block, Inc. (SQ) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
The Edgecore EAP101 Wi-Fi 6 AP is Now Plume WorkPass Certified
SMBs Can Now Deliver More than Just Powerful Wi-Fi HSINCHU, Taiwan–(BUSINESS WIRE)–Edgecore Networks, a leading…
RKVST showcases supply chain integrity, transparency and trust implementation at IETF 116 Hackathon
IETF members and new SCITT Community look to drive real-world implementations of IETF SCITT specifications…
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
TREK-AD Phase 2b study of eblasakimab fully enrolled, topline data readout expected early July 2023…
atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights
atai’s development candidates, such as RL-007 and GRX-917, all represent significant opportunities to address unmet…
Ultimovacs ASA: Notice of Annual General Meeting on 20 April 2023
Oslo, 24 March 2023, the Board of Directors hereby calls for the Annual General Meeting…
Ryvu Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Signed a collaboration agreement with BioNTech to develop and commercialize immunomodulatory small molecule therapeutics; deal…
CancerVax CEO Ryan Davies Speaks with University of Utah Chemistry Professor about the Future of Therapeutic Research
Dr. Ryan Looper, a chemistry Professor at the University of Utah, sat down with CancerVAX…
Ultimovacs ASA: Annual Report 2022
Oslo, 24 March 2023: Ultimovacs ASA (“Ultimovacs”, ticker ULTI), a clinical-stage biotechnology leader in novel…
OKYO Pharma Announces PDMR Dealing
LONDON and NEW YORK, March 24, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO;…
UCB Convening Notice to the General Meeting of theShareholders 2023
CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders…
Celyad Oncology appoints Georges Rawadi as its new CEO
MONT-SAINT-GUIBERT, Belgium, March 24, 2023 (GLOBE NEWSWIRE) — Celyad Oncology (Euronext & Nasdaq: CYAD) (the…
AstriVax, an innovative vaccine platform company, establishes scientific advisory board with world renowned leaders in vaccine development
Emmanuel Hanon, PhD, will chair the company’s scientific advisory board. Professor Peter Piot (MD, PhD)…
Bioasis Provides Update on Business Operations
NEW HAVEN, Conn., March 23, 2023 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the…
Celyad Oncology reports full year 2022 financial results and recent business highlights
Starting in 2023, Celyad Oncology is now entirely focused on its new business strategy with…
Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023
Call/webcast to feature updates on the discovery platform and pipeline, including updated data from the…
Inventiva announces the schedule of publication and presentation of its 2022 Full-Year Financial Results
Daix (France), Long Island City (New York, United States), March 23, 2023 – Inventiva (Euronext…
Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema
RZ402 is an oral therapy being developed as a potential alternative to anti-vascular growth factor…
Aptose Reports Results for the Fourth Quarter and Full Year 2022
─ APTIVATE Expansion Trial of Tuspetinib as Single Agent in Relapsed/Refractory AML Patients is Up…